Related Experiment Video
Updated: Jun 17, 2026
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
A novel radiosensitive SCID patient with a pronounced G(2)/M sensitivity
Wouter W Wiegant1, Matty Meyers, Nicole S Verkaik
1Department of Toxicogenetics, Leiden University Medical Center, The Netherlands.
Abstract:
V(D)J rearrangement in lymphoid cells involves repair of double-strand breaks (DSBs) through non-homologous end joining (NHEJ). Defects in this process lead to increased radiosensitivity and severe combined immunodeficiency (RS-SCID). Here, a SCID patient, M3, is described with a T(-)B(+)NK(+) phenotype but without causative mutations in CD3delta, epsilon, zeta or IL7Ralpha, genes specifically involved in T cell development. Clonogenic survival of M3 fibroblasts showed an increased sensitivity to the DSB-inducing agents ionizing radiation and bleomycin, as well as the crosslinking compound, mitomycin C. We did not observe inactivating mutations in known NHEJ genes and results of various DSB-repair assays in G(1) M3 cells were indistinguishable from those obtained with normal cells. However, we found increased chromosomal radiosensitivity at the G(2) phase of the cell cycle. Checkpoint analysis indicated functional G(1)/S and intra-S checkpoints after irradiation but impaired activation of the "early" G(2)/M checkpoint. Together these results indicate a novel class of RS-SCID patients characterized by the specific absence of T lymphocytes and associated with defects in G(2)-specific DSB repair. The pronounced G(2)/M radiosensitivity of the RS-SCID patient described here, suggests a defect in a putative novel and uncharacterized factor involved in cellular DNA damage responses and T cell development.
Insights
This study identifies a new form of radiosensitive severe combined immunodeficiency (RS-SCID) linked to impaired G2-phase DNA repair, affecting T cell development.
Area of Science:
- Immunology
- Genetics
- Cell Biology
Background:
- V(D)J recombination in lymphocytes relies on non-homologous end joining (NHEJ) for double-strand break (DSB) repair.
- Defects in DSB repair can cause radiosensitivity and severe combined immunodeficiency (SCID).
Purpose of the Study:
- To investigate the genetic and cellular basis of a unique SCID patient (M3) with a T(-)B(+)NK(+) phenotype.
- To identify the specific DNA repair defect responsible for the patient's radiosensitivity and immunodeficiency.
Main Methods:
- Phenotypic analysis of patient M3, including T, B, and NK cell counts.
- Clonogenic survival assays using fibroblasts exposed to DNA damaging agents (ionizing radiation, bleomycin, mitomycin C).
- Mutation analysis of known NHEJ genes and assessment of DSB repair assays in G1 phase cells.
- Cell cycle-specific radiosensitivity testing (G1 vs. G2) and checkpoint analysis (G1/S, intra-S, G2/M).
Main Results:
- Patient M3 exhibited increased sensitivity to ionizing radiation, bleomycin, and mitomycin C.
- No inactivating mutations were found in known NHEJ genes, and G1 DSB repair was normal.
- Significant chromosomal radiosensitivity was observed specifically in the G2 phase of the cell cycle.
- Functional G1/S and intra-S checkpoints were present, but the early G2/M checkpoint activation was impaired.
Conclusions:
- Patient M3 represents a novel class of radiosensitive SCID characterized by T-cell absence and defective G2-phase DSB repair.
- The findings suggest a defect in a previously uncharacterized factor crucial for G2/M checkpoint control and T cell development.
- This discovery highlights a specific role for G2-phase DNA damage response in T lymphocyte development.
